Do Weight-Loss Shots Help Keep Fat People's Hearts Healthy?
Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
No significant reduction in stroke risk despite strong benefits for other heart events.
Most cardiovascular drugs that reduce heart attacks also lower stroke risk. The fact that GLP-1 RAs didn’t here suggests they work differently—possibly more on plaque stability or inflammation than on blood flow or clotting.
Practical Takeaways
If you're overweight and at risk for heart disease, talk to your doctor about whether a GLP-1 RA like semaglutide could offer heart protection, not just weight loss.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
No significant reduction in stroke risk despite strong benefits for other heart events.
Most cardiovascular drugs that reduce heart attacks also lower stroke risk. The fact that GLP-1 RAs didn’t here suggests they work differently—possibly more on plaque stability or inflammation than on blood flow or clotting.
Practical Takeaways
If you're overweight and at risk for heart disease, talk to your doctor about whether a GLP-1 RA like semaglutide could offer heart protection, not just weight loss.
Publication
Journal
Frontiers in Cardiovascular Medicine
Year
2024
Authors
Raveena Kelkar, Nishad Barve, Rohan Kelkar, Sanjeev Kharel, Shalmi Khanapurkar, Rukesh Yadav
Related Content
Claims (5)
If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like Ozempic might lower your chances of having a heart attack by about 27% compared to taking a fake pill.
If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like those used for weight loss might lower your chances of needing heart artery procedures by about 22%.
If you're overweight or obese but don't have diabetes, taking GLP-1 drugs like Ozempic can lower your chances of having heart problems by about 1 in 4 compared to not taking them.
Semaglutide might be better than other similar weight-loss drugs at protecting heart health in people who are overweight or obese but don’t have diabetes.
Taking GLP-1 drugs like Ozempic doesn’t seem to lower the chance of having a stroke for people who are overweight or obese but don’t have diabetes, at least compared to taking a dummy pill.